Ossio

Startup
FUNDED
Ossio's investors video
PREVIOUS ROUNDS
$784,095
invested through OurCrowd in
1 previous round.
Access exclusive deals

Join for free and be notified of future investment opportunities

Sign in
WEBSITE
ossio.io
HealthcareHealthcare

Overview: Ossio

Ossio is developing a proprietary material for orthopedic implants that will convert into bone over time, reducing the need for follow-on surgeries, and contributing to safer patient outcomes.
READ MORE

Co Investors

READ MORE

Ossio Management Team

Brian Verrier

CEO

Mr. Verrier was Vice President & General Manager of Vascular Therapies at Covidien, where he grew the Peripheral Vascular Business from $700M to more than $1.2B. Before that he was Vice President of US Sales for Medtronic Vascular.

Orahn Preiss-Bloom

Founder & President, Strategic Innovation

Founder and COO/CTO of LifeBond, where developed two biosurgical product families to commercial stage and raised $60M, including from Johnson & Johnson Development Corporation. Biomechanics researcher at IDF Institute for Military Physiology and at Columbia University NY, Dept. of Orthopedic Surgery. M.Sc. in biomedical engineering from the Technion, Israel Institute of Technology.

Taly Lindner

PhD, Vice President of Scientific & Regulatory Affairs

Dr. Lindner joined Ossio after returning to Israel from the US, where she completed a post-doctoral fellowship at the California Institute of Technology (CalTech) in bio-inspired design. Previously, Taly worked as a Senior Engineer at Theracell, a biomedical start-up in California. Taly holds a Ph.D. and a B.Sc. in biomedical engineering from the Technion, Israel Institute of Technology, where she specialized in the biomechanics of biomaterials.

Moshe Shneor

CPA, MBA, Chief Financial Officer

Previously, Chief Executive at Pollogen (acquired by Lumenis) following service as Chief Financial & Operations Officer. Beforehand, Senior Manager at Ernst & Young, where focused on international hi-tech Nasdaq-traded corporations. MBA from Tel Aviv University.

Ronit Merchav-Feuermann

DVM, Medical Director

Dr. Merchav-Feuermann is a veterinary surgeon with advanced surgical training. She amassed 15 years of experience in veterinary orthopedics in both the academic environment in Israel, and in the private sector in the United States. Ronit is a leader in the Medical Department of Ossio and manages its extensive cutting-edge preclinical program. Ronit holds a DVM from the Hebrew University of Jerusalem.

undefined undefined

Ilan Uchitel

Vice President of Research & Development

Mr. Uchitel has more than 15 years of R&D experience in the medical device and defense industries. Previously, he served as VP R&D in various medical device companies in the fields of electrophysiology, invasive cardiology, and minimally invasive implantable maxillofacial solutions. Prior to that, Ilan held numerous R&D and project management positions at an elite technology unit of the Israeli Intelligence Corps. Ilan earned a B.Sc. in mechanical engineering, an M.Sc. in biomedical engineering and an MBA – all from Tel-Aviv University.

undefined undefined
READ MORE